5-Chloro-2-methyl-6-phenylamino-1H-benzoimidazole-4,7-dione

ID: ALA118296

PubChem CID: 10401815

Max Phase: Preclinical

Molecular Formula: C14H10ClN3O2

Molecular Weight: 287.71

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc2c([nH]1)C(=O)/C(=N/c1ccccc1)C(Cl)=C2O

Standard InChI:  InChI=1S/C14H10ClN3O2/c1-7-16-11-12(17-7)14(20)10(9(15)13(11)19)18-8-5-3-2-4-6-8/h2-6,19H,1H3,(H,16,17)/b18-10+

Standard InChI Key:  WEBCSNRNXPNTCE-VCHYOVAHSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.4250   -1.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4250   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8542   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8542   -1.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292   -2.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6417   -1.9000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6417   -0.5667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1542   -1.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5750   -0.4000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292    0.4208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292   -2.8792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5750   -2.0542    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.2917   -0.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6708   -1.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3000   -1.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0042   -0.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7292   -0.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0125   -2.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7375   -1.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  5  1  0
  4  2  1  0
  5  6  2  0
  6  1  1  0
  7  1  1  0
  8  2  1  0
  9  7  2  0
 10  3  2  0
 11  4  2  0
 12  6  1  0
 13  5  1  0
 14 10  1  0
 15  9  1  0
 16 14  2  0
 17 14  1  0
 18 17  2  0
 19 16  1  0
 20 18  1  0
  9  8  1  0
  3  4  1  0
 20 19  2  0
M  END

Alternative Forms

Associated Targets(Human)

HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK13 Tchem MAP kinase p38 (1586 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NIH3T3 (5395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk3 Mitogen-activated protein kinase 3 (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 Mitogen-activated protein kinase 1 (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 287.71Molecular Weight (Monoisotopic): 287.0462AlogP: 3.15#Rotatable Bonds: 1
Polar Surface Area: 78.34Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.12CX Basic pKa: 5.55CX LogP: 1.52CX LogD: -0.08
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.85Np Likeness Score: -0.65

References

1. Hong SY, Chung KH, You HJ, Choi IH, Chae MJ, Han JY, Jung OJ, Kang SJ, Ryu CK..  (2004)  Synthesis and biological evaluation of benzimidazole-4,7-diones that inhibit vascular smooth muscle cell proliferation.,  14  (13): [PMID:15177474] [10.1016/j.bmcl.2004.04.051]
2. Hong SY, Kwak KW, Ryu CK, Kang SJ, Chung KH..  (2008)  Antiproliferative effects of 6-anilino-5-chloro-1H-benzo[d]imidazole-4,7-dione in vascular smooth muscle cells.,  16  (2): [PMID:17981046] [10.1016/j.bmc.2007.10.069]
3. Ryu CK, Lee Y, Park SG, You HJ, Lee RY, Lee SY, Choi S..  (2008)  3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment.,  16  (22): [PMID:18930405] [10.1016/j.bmc.2008.09.062]

Source